Clinical Trials in Los Angeles

Showing 3421-3440 of 16,901 trials

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

NCT05277571

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB1381 (intravenous and subcutaneous) in healthy study participants and after repeat intravenous dosing in study participants with atopic dermatitis. Efficacy will be assessed following repeat intravenous dosing versus placebo in study participants with atopic dermatitis.

Atopic Dermatitis

UCB Biopharma SRL273 participantsStarted Mar 2022

Beverly Hills, California, United States • Glendale, California, United States • Los Angeles, California, United States +13 more locations

Active Not Recruiting< 1 mile

IN.PACT™ AV Access Post-Approval Study (PAS002)

NCT04543539

Long-term safety will be summarized

Arteriovenous FistulaArteriovenous Fistula StenosisArteriovenous Fistula Occlusion+1 more

Medtronic240 participantsStarted Nov 2020

Los Angeles, California, United States • Stanford, California, United States • New Haven, Connecticut, United States +17 more locations

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

IN.PACT™ AV Access Post-Approval Study (PAS002)

Find Trials by Condition in Los Angeles

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Neurophysiologic Biomarkers in Rett Syndrome

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

Opioids and Social Support Enhanced Extinction Effects

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

PRV-015 in Gluten-free Diet Non-responsive Celiac Disease

Gilteritinib for the Treatment of ALK NSCLC

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

IBRX-042 In Participants With HPV-Associated Tumors

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1

Inappropriate Sinus Tachycardia Registry

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients